VOYAGER THERAPEUTICS INC
VYGRNASDAQ🏆 #3124 by market capEarnings Nov 9US Equity
$3.20▲ $0.03 (+0.95%)
Market closed · at close1h—
24h▲ 0.9%
7d▲ 3.9%
14d▲ 6.7%
30d▼ 1.5%
1y▼ 5.6%
🏦Market Cap
$193M
Small Cap
📈Revenue Growth (YoY)
-19.1%
Declining
📊Gross Margin
—
💵FCF Margin
164.3%
Strong
⚖️P/S Ratio
5.7x
Fair
Otter Score
43
Weak
📊
Analyst Ratings
Price
$3.20
Total
21
Raised
1
Lowered
3
Avg PT
$14.40
H / L
$18 / $8
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-03-17 |
Wedbush | Reiterated | Outperform | 2025-08-07 |
Canaccord Genuity | Reiterated | Buy | 2025-03-13 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-03-12 |
Wells Fargo | Reiterated | Overweight | 2025-03-12 |
Oppenheimer | Reiterated | Outperform | 2024-05-15 |
Truist Securities | Reiterated | Buy | 2023-05-10 |
Chardan Capital | Reiterated | Neutral | 2021-11-03 |
Baird | Upgraded | Neutral → Outperform | 2021-10-07 |
Morgan Stanley | Reiterated | Equal Weight | 2021-04-19 |
BTIG | Downgraded | Buy → Neutral | 2021-02-03 |
Raymond James | Downgraded | Strong Buy → Outperform | 2020-11-10 |
Nomura | Reiterated | Buy | 2020-03-30 |
Benchmark | Reiterated | Buy | 2020-03-19 |
H.C. Wainwright | Reiterated | Buy | 2018-06-04 |
Evercore ISI Group | Downgraded | Outperform → In Line | 2018-03-12 |
BTIG Research | Reiterated | Buy | 2017-12-20 |
Stifel | Reiterated | Buy | 2017-10-23 |
Stifel Nicolaus | Reiterated | Buy | 2017-10-23 |
PiperJaffray | Reiterated | Overweight | 2015-12-07 |
Cowen & Co. | Reiterated | Outperform | 2015-12-07 |
One row per institution, most recent rating